We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Search Results

Showing 1-20 of 10,000 results
  1. Association of IL-4 (− 590 C/T) and IL-6 (− 174 G/C) gene polymorphism in South Indian CKD patients

    Aim

    The present study was undertaken to examine the role of IL-4 (− 590 C/T) (rs2243250) and IL-6 (− 174G/C) (rs1800795) polymorphism and the serum...

    Vandit Sevak, Rathika Chinniah, ... Balakrishnan Karuppiah in Egyptian Journal of Medical Human Genetics
    Article Open access 06 February 2024
  2. PCR-positive meningococcal CSF infection without pleocytosis but high IL-6 and IL-8

    Background

    Meningococcal meningitis is still a severe disease causing high mortality and morbidity rates. Early diagnosis is crucial to ensure prompt...

    Susanne Dyckhoff-Shen, Hans-Walter Pfister, ... Matthias Klein in Infection
    Article Open access 27 April 2024
  3. Assessment of selected interleukins (IL-6, IL-17A, IL-18, IL-23) and chemokines (RANTES, IP-10) in children with acute and chronic urticaria

    Background

    Urticarial lesions develop as a result of the activation of mast cells which, through the release of mediators, influence the formation of...

    Anna Góra, Maciej Przybył, ... Edyta Machura in Italian Journal of Pediatrics
    Article Open access 21 December 2022
  4. Serum concentrations of proinflammatory biomarker interleukin-6 (IL-6) as a predictor of postoperative complications after elective colorectal surgery

    Background

    The aim of this prospective study was to evaluate the role of serum IL-6 as a potential predictive biomarker of postoperative complications...

    Vladimír Procházka, Lukáš Lacina, ... Zdeněk Kala in World Journal of Surgical Oncology
    Article Open access 14 December 2023
  5. The double-edged effects of IL-6 in liver regeneration, aging, inflammation, and diseases

    Interleukin-6 (IL-6) is a pleiotropic cytokine and exerts its complex biological functions mainly through three different signal modes, called cis- , trans-...

    Min-Jun Wang, Hai-Ling Zhang, ... Jin Hou in Experimental Hematology & Oncology
    Article Open access 18 June 2024
  6. P. gingivalis in oral-prostate axis exacerbates benign prostatic hyperplasia via IL-6/IL-6R pathway

    Background

    Benign prostatic hyperplasia (BPH) is the most common disease in elderly men. There is increasing evidence that periodontitis increases the...

    Shuang-Ying Wang, Yi Cai, ... Xian-Tao Zeng in Military Medical Research
    Article Open access 20 May 2024
  7. Cytokine storm and translating IL-6 biology into effective treatments for COVID-19

    As of May 3, 2023, the Coronavirus disease 2019 (COVID-19) pandemic has resulted in more than 760 million confirmed cases and over 6.9 million...

    Tiantian Li, Dongsheng Wang, ... Xiaoling Xu in Frontiers of Medicine
    Article 29 December 2023
  8. The involvement of RIPK4 in TNF-α-stimulated IL-6 and IL-8 production by melanoma cells

    Purpose

    The receptor-interacting protein kinase (RIPK4) has an oncogenic function in melanoma, regulates NF-κB and Wnt/β-catenin pathways, and is...

    Ewelina Madej, Anna Lisek, ... Agnieszka Wolnicka-Glubisz in Journal of Cancer Research and Clinical Oncology
    Article Open access 24 April 2024
  9. Association between psychiatric admissions in patients with schizophrenia and IL-6 plasma levels polygenic score

    Schizophrenia diagnosis and admission history were associated with a polygenic score (PGS) for schizophrenia based on a subset of variants that act...

    Fernando Facal, Manuel Arrojo, ... Javier Costas in European Archives of Psychiatry and Clinical Neuroscience
    Article 16 March 2024
  10. MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors

    Background

    Few studies have reported reliable prognostic factors for immune checkpoint inhibitors (ICIs) in renal cell carcinoma (RCC). Therefore, we...

    Hirotaka Nagasaka, Takeshi Kishida, ... Tetsuro Sasada in International Journal of Clinical Oncology
    Article Open access 06 April 2024
  11. Mitochondrial DNA is a key driver in cigarette smoke extract-induced IL-6 expression

    Smoking is an independent risk factor for atherosclerosis, the primary pathogenesis of which is inflammation. We recently reported that cigarette...

    Yusuke Kobayashi, Chiemi Sakai, ... Mari Ishida in Hypertension Research
    Article 17 October 2023
  12. Serum Sirt6 as a Potential Biomarker for Osteoarthritis and its Correlation with IL-6 Alterations

    Objective

    The study aimed to assess Sirt6 levels in serum of knee osteoarthritis (OA) patients compared to healthy individuals to evaluate its...

    Nikhil Gupta, Anchal Arora, ... Abhinav Kanwal in Indian Journal of Orthopaedics
    Article 19 July 2024
  13. Elevated serum IFN-γand IFN-γ/IL-6 ratio in Kikuchi-Fujimoto disease

    Background

    Kikuchi-Fujimoto disease (KFD) is typically a benign, self-limiting inflammatory disease. The diagnosis of KFD can be challenging for...

    Tingyan He, Zixuan Shen, ... Jun Yang in Pediatric Rheumatology
    Article Open access 22 August 2023
  14. Paradoxical effect of anti-inflammatory drugs on IL-6 mRNA expression in patients with PTSD during treatment

    The pathophysiology of posttraumatic stress disorder (PTSD) is associated with the activation of the innate immune system, including cytokines like...

    Cosima Rhein, Isabella Apelt, ... Yesim Erim in Journal of Neural Transmission
    Article Open access 13 April 2024
  15. An epithelial gene signature of trans-IL-6 signaling defines a subgroup of type 2-low asthma

    Background

    Asthma is stratified into type 2-high and type 2-low inflammatory phenotypes. Limited success has been achieved in developing drugs that...

    Zaid W. El-Husseini, Dmitry Khalenkow, ... Reinoud Gosens in Respiratory Research
    Article Open access 07 December 2023
  16. IL-6 induces periostin production in human ACL remnants: a possible mechanism causing post-traumatic osteoarthritis

    Objective

    Perostin (POSTN) and IL-6 consistently elevated after ACL injury, and ACL has been proposed as the major source of POSTN. However, there is...

    Tzu-Hao Tseng, Chien-Lin Chen, ... Tai-Horng Young in Journal of Orthopaedic Surgery and Research
    Article Open access 02 November 2023
  17. Diagnostic value of IL-6 for patients with asthma: a meta-analysis

    Background

    IL-6 is a pleotropic cytokine that acts as a pro-inflammatory mediator and acute-phase response inducer, but has also been reported to...

    Ruilin Pan, Shougang Kuai, ... Yubao Cui in Allergy, Asthma & Clinical Immunology
    Article Open access 12 May 2023
  18. Associations between IL-1α, IL-1β, TNFα, and IL-6 variations, and susceptibility to transposition of the great arteries

    Background

    To evaluate the relationship between IL-1α -889C/T (rs1800587), IL-1β -511C > T (rs16944), TNFα -308G > A (rs1800629), TNFα -238G > A...

    Latife Atasoy Karakas, Duygu Tugrul, ... Yunus Kasim Terzi in BMC Cardiovascular Disorders
    Article Open access 19 May 2022
  19. IL-6 Levels Correlate with Prognosis and Immunosuppressive Stromal Cells in Patients with Colorectal Cancer

    Background

    The prognosis for patients with colorectal cancer (CRC) is determined by tumor characteristics as well as the host immune response. This...

    Tsunenori Yamamoto, Ryouichi Tsunedomi, ... Hiroaki Nagano in Annals of Surgical Oncology
    Article 24 May 2023
  20. Serum IL-6 as a Surrogate Biomarker of Post-operative Complications in Invasive Orthopaedic Surgeries: A Prospective Observational Study

    Background

    Interleukin-6 (IL-6) is a cytokine released in response to tissue injury. Elevated serum IL-6 levels in trauma patients have been linked...

    Kanchana Laishram, Bhaskar Borgohain, ... Sachlang Debbarma in Indian Journal of Orthopaedics
    Article 25 June 2024
Did you find what you were looking for? Share feedback.